Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Gains from Sales and Divestitures (2023 - 2024)

Historic Gains from Sales and Divestitures for Core Laboratories (CLB) over the last 2 years, with Q4 2024 value amounting to $256724.0.

  • Core Laboratories' Gains from Sales and Divestitures fell 2378.55% to $256724.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $256724.0, marking a year-over-year decrease of 2378.55%. This contributed to the annual value of $256724.0 for FY2024, which is 2378.55% down from last year.
  • As of Q4 2024, Core Laboratories' Gains from Sales and Divestitures stood at $256724.0, which was down 2378.55% from $336844.0 recorded in Q4 2023.
  • In the past 5 years, Core Laboratories' Gains from Sales and Divestitures registered a high of $336844.0 during Q4 2023, and its lowest value of $256724.0 during Q4 2024.